Ryan E. Michael

Person

Newton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 12,076,405
- Issue date Sep 3, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 12,048,748
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone and indazole compounds for the degradation of EGFR
- Patent number 11,673,902
- Issue date Jun 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 11,185,592
- Issue date Nov 30, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,905,768
- Issue date Feb 2, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 10,660,968
- Issue date May 26, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,646,575
- Issue date May 12, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
- Publication number 20240158418
- Publication date May 16, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20240076300
- Publication date Mar 7, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF RET
- Publication number 20230233692
- Publication date Jul 27, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20230110648
- Publication date Apr 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230095223
- Publication date Mar 30, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230014124
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20210106688
- Publication date Apr 15, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20190076541
- Publication date Mar 14, 2019
- C4 Theraprutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20190076540
- Publication date Mar 14, 2019
- C4 Theraprutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ryan E. Michael

Person

Patents Grantslast 30 patents

Heterocyclic degronimers for target protein degradation

Spirocyclic degronimers for target protein degradation

Isoindolinone and indazole compounds for the degradation of EGFR

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

Patents Applicationslast 30 patents

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

COMPOUNDS FOR TARGETED DEGRADATION OF RET

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION